Co-repressor activity of scaffold attachment factor B1 requires sumoylation

Biochemical and Biophysical Research Communications

Volumn 408, Issue 4, 2011, Pages 516-522

  Garee, Jason P ^a   Meyer, Rene ^a,b   Oesterreich, Steffi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Scaffold attachment factor B1; Sumoylation; Transcriptional repression

Indexed keywords

LIGASE; NUCLEAR PROTEIN; PIAS1 ENZYME; SCAFFOLD ATTACHMENT FACTOR B1; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; SUMOYLATION;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CO-REPRESSOR PROTEINS; CONSENSUS SEQUENCE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PROTEIN INHIBITORS OF ACTIVATED STAT; RECEPTORS, ESTROGEN; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMO-1 PROTEIN; SUMOYLATION; TRANSCRIPTION, GENETIC; UBIQUITINS;

EID: 79956197438     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.040     Document Type: Article

References (19)

1. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
2. Kerscher O., Felberbaum R., Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 2006, 22:159-180.
3. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 2004, 73:355-382.
4. Yeh E.T. SUMOylation and De-SUMOylation: wrestling with life's processes. J. Biol. chem. 2009, 284:8223-8227.
5. Mukhopadhyay D., Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 2007, 32:286-295.
6. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 2005, 15:536-541.
7. Garee J.P., Oesterreich S. SAFB1's multiple functions in biological control-lots still to be done. J. Cell. Biochem. 2010, 109:312-319.
8. Hammerich-Hille S., Kaipparettu B.A., Tsimelzon A., Creighton C.J., Jiang S., Polo J.M., Melnick A., Meyer R., Oesterreich S. SAFB1 Mediates repression of immune regulators and apoptotic genes in breast cancer cells. J. Biol. Chem. 2010, 285:3608-3616.
9. Lee Y.-B., Colley S., Norman M., Biamonti G., Uney J.B. SAFB re-distribution marks steps of the apoptotic process. Exp. Cell Res. 2007, 313:3914-3923.
10. Townson S.M., Sullivan T., Zhang Q., Clark G.M., Osborne C.K., Lee A.V., Oesterreich S. HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer. Clin. Cancer Res. 2000, 6:3788-3796.
11. Weighardt F., Cobianchi F., Cartegni L., Chiodi I., Villa A., Riva S., Biamonti G. A novel hnRNP protein (HAP/SAF-B) enters a subset of hnRNP complexes and relocates in nuclear granules in response to heat shock. J. Cell Sci. 1999, 112:1465-1476.
12. Chan C.W., Lee Y.-B., Uney J., Flynn A., Tobias J.H., Norman M. A novel member of the SAF (scaffold attachment factor)-box protein family inhibits gene expression and induces apoptosis. Biochem. J. 2007, 407:355-362.
13. Townson S.M., Dobrzycka K.M., Lee A.V., Air M., Deng W., Kang K., Jiang S., Kioka N., Michaelis K., Oesterreich S. SAFB2 a new scaffold attachment factor homolog and estrogen receptor corepressor. J. Biol. Chem. 2003, 278:20059-20068.
14. Townson S.M., Kang K., Lee A.V., Oesterreich S. Structure-function analysis of the estrogen receptor î± corepressor scaffold attachment factor-B1. J. Biol. Chem. 2004, 279:26074-26081.
15. Oesterreich S., Zhang Q., Hopp T., Fuqua S.A.W., Michaelis M., Zhao H.H., Davie J.R., Osborne C.K., Lee A.V. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. Mol. Endocrinol. 2000, 14:369-381.
16. Debril M.-B., Dubuquoy L., Feige J.-N., Wahli W., Desvergne B., Auwerx J., Gelman L. Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity. J. Mol. Endocrinol. 2005, 35:503-517.
17. Jiang S., Meyer R., Kang K., Osborne C.K., Wong J., Oesterreich S. Scaffold attachment factor SAFB1 suppresses estrogen receptor {alpha}-mediated transcription in part via interaction with nuclear receptor corepressor. Mol. Endocrinol. 2006, 20:311-320.
18. Ivanova M., Dobrzycka K.M., Jiang S., Michaelis K., Meyer R., Kang K., Adkins B., Barski O.A., Zubairy S., Divisova J., Lee A.V., Oesterreich S. Scaffold attachment factor B1 functions in development, growth, and reproduction. Mol. Cell. Biol. 2005, 25:2995-3006.
19. Ren J., Gao X., Jin C., Zhu M., Wang X., Shaw A., Wen L., Yao X., Xue Y. Systematic study of protein sumoylation: development of a site-specific predictor of SUMOsp 2.0. Proteomics 2009, 9:3409-3412.